Esperion Therapeutics: Q3 Earnings Snapshot
In this article:
ANN ARBOR, Mich. (AP) — ANN ARBOR, Mich. (AP) — Esperion Therapeutics Inc. (ESPR) on Tuesday reported a loss of $41.3 million in its third quarter.
The Ann Arbor, Michigan-based company said it had a loss of 37 cents per share.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.
The biopharmaceutical company posted revenue of $34 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $30.8 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR
